IP Library Granted Patent US 7,914,470
Granted Patent B2
US 7,914,470 · App. 10/815,384 · Granted Mar 29, 2011

Ultrasonic method and device for wound treatment

Assignee: Celleration, Inc.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,914,470
App. No.
10/815,384
Granted
Mar 29, 2011
Kind
B2
Abstract

An apparatus and method are provided for applying a medicament to tissue, and delivering ultrasonic energy from a non-contact distance from the tissue to the medicament and to the tissue, wherein the ultrasonic energy has intensity capable of penetrating the wound tissue to a beneficial depth to provide a therapeutic effect to the tissue, and of sonicating the medicament for causing the medicament to penetrate the tissue to a beneficial depth to provide a therapeutic effect to the tissue.

Claims (59)

1. A method for treating tissue using ultrasonic energy comprising the steps of:

applying a medicament to tissue before applying ultrasonic energy; and

delivering ultrasonic energy from a non-contact distance from the tissue and the medicament to the medicament and to the tissue, wherein the ultrasonic energy is delivered simultaneously with delivery of a liquid spray and the ultrasonic energy has intensity capable of penetrating the tissue to a beneficial depth to provide a therapeutic effect to the tissue, and wherein the ultrasonic energy sonicates the medicament and causes the medicament to penetrate the tissue to a beneficial depth to provide a therapeutic effect to the tissue.

2. The method according to claim 1 , further including the step of generating the ultrasonic energy with a particular amplitude indicative of an intensity capable of achieving the therapeutic effect.

3. The method according to claim 2 , further including the step of generating the ultrasonic energy with a frequency capable of achieving the particular amplitude.

4. The method according to claim 3 , wherein the frequency is in the range of 20 kHz-5 MHz.

5. The method according to claim 3 , wherein the frequency is in the range of 20-200 kHz.

6. The method according to claim 3 , wherein the frequency is in the range of 20-40 kHz.

7. The method according to claim 2 , wherein the particular amplitude is at least 3 microns.

8. The method according to claim 2 , wherein the particular amplitude is at least 10 microns.

9. The method according to claim 1 , wherein the applying step is performed prior to the delivery step.

10. The method according to claim 1 , wherein the applying step is performed during the delivering step.

11. The method according to claim 1 , wherein the steps of the method are included in a series of treatments wherein another treatment of the series of treatments is selected from the group consisting of:

the treatment including the steps of delivering ultrasonic energy from a non-contact distance to the tissue simultaneous with delivery of a spray to the tissue, wherein the ultrasonic energy has an intensity capable of penetrating the tissue to a beneficial depth to provide a therapeutic effect to the tissue and sonicating the spray for causing the spray to penetrate the tissue to a beneficial depth to provide a therapeutic effect to the tissue;

the treatment including the steps of delivering ultrasonic energy from a non-contact distance to the tissue through a substantial expanse of a substantially purely gaseous medium to the tissue, wherein the ultrasonic energy has an intensity capable of penetrating the tissue to a beneficial depth to provide a therapeutic effect to the tissue; and

the treatment including the steps of the method of the invention, wherein a different medicament is applied.

12. The method according to claim 1 , wherein the medicament is selected from at least one member of the group consisting of: an antibiotic, an ointment, cream, gel, liquid, salve, oil, powder, antibacterial agent, antiseptic agent, insulin, analgesic agent, conditioner, surfactant, emollient, or other active ingredient.

13. The method according to claim 1 , wherein the step of delivering includes the step of providing means for delivering the ultrasonic energy at a distance from 2.5 mm-51 cm from the tissue and the medicament.

14. The method according to claim 1 , wherein the therapeutic effect is selected from at least one member of the group consisting of increasing blood flow to the tissue, providing a local anesthetic effect and stimulating cell growth.

15. The method of claim 1 , wherein the liquid spray includes a medicament.

16. A method for treating a wound comprising the steps of:

applying a medicament to a wound before applying ultrasonic energy;

providing a transducer having a distal radiation surface for generating and emitting ultrasonic energy;

introducing a liquid to the distal radiation surface to produce a spray; and

delivering the generated and emitted ultrasonic energy to the wound through the spray from a non-contact distance from the surface of the wound and from the medicament applied to the wound, wherein the generated and emitted ultrasonic energy penetrates the wound tissue to a beneficial depth to provide a therapeutic effect for decreasing the healing time for the wound, and wherein the non-contact distance is at least 2.5 mm from the surface of the wound.

17. The method according to claim 16 , wherein the generating step includes generating the ultrasonic energy with a particular amplitude indicative of an intensity capable of achieving the therapeutic effect.

18. The method according to claim 17 , wherein the generating step further includes the step of generating the ultrasonic energy with a frequency capable of achieving the particular amplitude.

19. The method according to claim 18 , wherein the frequency is in the range of 20 kHz-5 MHz.

20. The method according to claim 18 , wherein the frequency is in the range of 20-200 kHz.

21. The method according to claim 18 , wherein the frequency is in the range of 20-40 kHz.

22. The method according to claim 16 , wherein said distal radiation surface has a surface area dimensioned for achieving delivery of the ultrasonic energy to the wound with an intensity capable of achieving the therapeutic effect.

23. The method according to claim 16 , wherein said distal radiation surface has a rounded perimeter for achieving delivery of the ultrasonic energy to the wound with an intensity capable of achieving the therapeutic effect.

24. The method according to claim 16 , wherein one or more of the following features of the distal radiation surface are selected to achieve delivery of ultrasonic energy to the wound with an intensity capable of achieving the therapeutic effect: a size of a surface area of the distal radiation surface or a shape of a peripheral boundary of the distal radiation surface.

25. The method of claim 16 , wherein one or more of the following features of the distal radiation surface are selected to achieve the therapeutic effect: a size of a surface area of the distal radiation surface, a shape of a peripheral boundary of the distal radiation surface, a shape of the curvature of the distal radiation surface selected from one of flat, concave, convex and a combination thereof.

26. The method according to claim 16 , wherein the radiation surface is positioned from 2.5 mm-51 cm from the surface of the wound.

27. The method according to claim 16 , wherein the generating step includes the steps of generating the ultrasonic energy with a constant or modulated frequency having a wave form selected from the group consisting of sinusoidal, rectangular, trapezoidal, and triangular wave forms.

28. The method according to claim 16 , wherein the liquid does not include a medicament.

29. The method according to claim 16 , wherein the medicament penetrates the wound to a beneficial depth to provide a therapeutic effect to the wound.

30. The method according to claim 29 , wherein the medicament is selected from one or more members of the group consisting of: an antibiotic, an ointment, cream, gel, liquid, salve, oil, powder, antibacterial agent, antiseptic agent, insulin, analgesic agent, conditioner, surfactant, emollient, or other active ingredient.

31. The method according to claim 16 , wherein the medicament is selected from at least one member of the group consisting of: an antibiotic, an ointment, cream, gel, liquid, salve, oil, powder, antibacterial agent, antiseptic agent, insulin, analgesic agent, conditioner, surfactant, emollient, or other active ingredient.

32. The method according to claim 16 , wherein the therapeutic effect is selected from one or more members of the group consisting of increasing blood flow to the tissue, providing a local anesthetic effect and stimulating cell growth.

33. The method of claim 16 , wherein the medicament is applied before the ultrasonic energy is delivered to the wound.

34. The method of claim 16 , wherein the medicament is applied during delivery of the ultrasonic energy to the wound.

35. The method of claim 16 , wherein the liquid includes a medicament.

36. A method for treating a wound comprising the steps of:

applying a medicament to a wound before applying ultrasonic energy;

generating ultrasonic energy having a particular amplitude and a particular frequency; and

delivering the generated ultrasonic energy to the wound through a liquid spray from a non-contact distance from the medicament and from the surface of the wound, wherein the generated ultrasonic energy penetrates the wound tissue to a beneficial depth to provide a therapeutic effect for decreasing the healing time for the wound, wherein the particular amplitude is indicative of an intensity capable of achieving the therapeutic effect, and wherein the non-contact distance is at least 2.5 mm from the surface of the wound.

37. The method according to claim 36 , wherein the particular amplitude is at least 3 microns.

38. The method according to claim 36 , wherein the particular amplitude is at least 10 microns.

39. The method of claim 36 , wherein the liquid spray does not include a medicament.

40. The method according to claim 36 , wherein the medicament penetrates the wound to a beneficial depth to provide a therapeutic effect to the wound.

41. The method according to claim 40 , wherein the medicament is selected from one or more members of the group consisting of: an antibiotic, an ointment, cream, gel, liquid, salve, oil, powder, antibacterial agent, antiseptic agent, insulin, analgesic agent, conditioner, surfactant, emollient, or other active ingredient.

42. The method according to claim 36 , wherein the medicament is selected from at least one member of the group consisting of: an antibiotic, an ointment, cream, gel, liquid, salve, oil, powder, antibacterial agent, antiseptic agent, insulin, analgesic agent, conditioner, surfactant, emollient, or other active ingredient.

43. The method according to claim 36 , wherein the step of delivering includes the step of providing means for delivering the ultrasonic energy at a distance from 2.5 mm-51 cm from the wound.

44. The method according to claim 36 , wherein the therapeutic effect is selected from one or more members of the group consisting of increasing blood flow to the tissue, providing a local anesthetic effect and stimulating cell growth.

45. The method of claim 36 , wherein the medicament is applied before the ultrasonic energy is delivered to the wound.

46. The method of claim 36 , wherein the medicament is applied during delivery of the ultrasonic energy to the wound.

47. The method of claim 36 , wherein the liquid spray includes a medicament.

Assignments (11)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 6, 2020
From: CELULARITY INC.
To: SANUWAVE HEALTH, INC.
Reel/Frame 054299/0846 →
SECURITY INTEREST Recorded Aug 7, 2020
From: SANUWAVE HEALTH, INC.
To: NH EXPANSION CREDIT FUND HOLDINGS LP
Reel/Frame 053435/0842 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 8, 2020
From: ALLIQUA BIOMEDICAL, INC.
To: CELULARITY INC.
Reel/Frame 053152/0144 →
RELEASE OF SECURITY INTEREST Recorded May 9, 2018
From: PERCEPTIVE CREDIT OPPORTUNITIES FUND, LP C/O PERCEPTIVE ADVISORS LLC
To: ALQA CEDAR, INC.
Reel/Frame 045756/0204 →
CHANGE OF ASSIGNEE ADDRESS Recorded Mar 28, 2016
From: CELLERATION, INC.
To: ALLIQUA BIOMEDICAL, INC.
Reel/Frame 038274/0778 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 21, 2015
From: CELLERATION, INC.
To: ALLIQUA BIOMEDICAL, INC.
Reel/Frame 036140/0913 →
SECURITY INTEREST Recorded May 29, 2015
From: ALQA CEDAR, INC.
To: PERCEPTIVE CREDIT OPPORTUNITIES FUND, LP C/O PERCEPTIVE ADVISORS LLC
Reel/Frame 035745/0313 →
EMPLOYMENT AGREEMENT Recorded Feb 7, 2008
From: BABAEV, EILAZ
To: ADVANCED MEDICAL APPLICATIONS, INC.
Reel/Frame 020488/0275 →
MERGER Recorded Mar 30, 2007
From: CELLERATION, INC.
To: CELLERATION, INC.
Reel/Frame 019098/0923 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 30, 2007
From: ADVANCED MEDICAL APPLICATIONS, INC., D/B/A CELLERATION, INC.
To: CELLERATION, INC.
Reel/Frame 019107/0910 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 1, 2004
From: BABAEV, ELIAZ
To: ADVANCED MEDICAL APPLICATIONS, INC., D/B/A CELLERATION
Reel/Frame 015174/0890 →
Continuity (3)
Continuation In Part 10409272 · Apr 7, 2003
Continuation In Part 09669312 · Sep 25, 2000
Related Publication 20040186384A1 · Sep 23, 2004